Skip to content

Assessing the Stability of Transcranial Magnetic Stimulation Plasticity Responses

Assessing the Reliability and Influence of Timing of Exercise on Transcranial Magnetic Stimulation (TMS) Neuroplasticity Measures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03034629
Enrollment
16
Registered
2017-01-27
Start date
2017-05-22
Completion date
2021-09-27
Last updated
2021-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The overall goal of this proposed study is to assess the reliability of plasticity measured by transcranial magnetic stimulation (TMS) interleaved with intermittent theta-burst stimulation plasticity measures and to assess the influence of an acute bout of aerobic exercise on TMS plasticity measures.

Interventions

BEHAVIORALShort-term aerobic exercise

One bout of moderate intensity exercise (75% of maximal predicated heart rate).

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult males and females aged 18-70 years old. * Primary language is English * Exercise clearance

Exclusion criteria

* Presence of cognitive, neurologic or orthopedic conditions that could affect performance of the testing and training procedures * History of migraines * History of fainting spells of unknown or undetermined etiology that might constitute seizures * History of seizures, diagnosis of epilepsy, history of abnormal (epileptiform) EEG or family history of treatment resistance epilepsy * Any current history of psychiatric illness * Any unstable medical condition * No medication is an absolute exclusion from TMS. Medications will be reviewed by the Principal Investigator and a decision about inclusion will be made based on the following: * The subject's past medical history, drug does, history of recent medication changes or duration of treatment, and combination with other central nervous system active drugs. * The published TMS guidelines review medications to considered with TMS (Rossi, Hallet, Rossini, Pascual-Leone, & Safety of TMS Consensus Group, 2009) * Any metal in the brain, skull or elsewhere unless approved by the responsible MD * Any medical devices (i.e. Cardiac pacemaker, deep brain stimulator, medication infusion pump, cochlear implant, vagal nerve stimulator) * Intracranial lesion * Substance abuse or dependence within the past six months

Design outcomes

Primary

MeasureTime frameDescription
Change in cortical synaptic plasticityBaseline, 1 weekAs measured via Transcranial Magnetic Stimulation (TMS) in mean motor evoked potential (MEP) amplitude

Secondary

MeasureTime frameDescription
Assess TMS plasticity measures on healthy individuals after an acute bout of exerciseBaseline, 3 weeksAs measured via Transcranial Magnetic Stimulation (TMS) in mean motor evoked potential (MEP) amplitude after an acute bout of aerobic exercise

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026